Serum anti-CRP antibodies differentiate etiology and predict relapse in acute tubulointerstitial nephritis.

Jun-Wen HuangTao SuYing TanJin-Wei WangJia-Wei TangSu-Xia WangGang LiuMing-Hui ZhaoLi Yang

Published in: Clinical kidney journal (2021)

Serum anti-CRP antibody could be used to differentiate late-onset AI-ATIN and predict relapse of ATIN at the time of renal biopsy. The CRP linear peptides PT6 and PT17 could be used as coating antigens to detect anti-CRP antibodies, which may provide more information for the clinical assessment of ATIN.

Keyphrases

dendritic cells
late onset
immune response
early onset
liver failure
free survival
healthcare
artificial intelligence
machine learning
intensive care unit
acute respiratory distress syndrome
neural network